West Virginia Code of State Rules › Agency 15 - Pharmacy › Title 15 - LEGISLATIVE RULE WEST VIRGINIA BOARD OF PHARMACY › Series 15-08 - Controlled Substances Monitoring Program › Section 15-8-3 - Prescription Monitoring Program

Current through Register Vol. XLI, No. 28, July 12, 2024
3.1.
				Each time a Schedule II, III, IV, or V Controlled Substance, drug of concern,
				or opioid antagonist is dispensed for out-patient use, the medical services
				provider, health care facility, or pharmacy that dispensed the controlled
				substance, drug of concern, or opioid antagonist shall transmit to the central
				repository the information required by West Virginia Code §
									60A-9-4 in
				the appropriate American Society for Automation in Pharmacy format used by the
				central repository for reporting to it. This includes the following:
3.1.a. The name, address, pharmacy
				prescription number and Drug Enforcement Administration controlled substance
				registration number of the dispensing pharmacy or the dispensing medical
				services provider;
3.1.b. The full
				legal name, address and birth date of the recipient. When reporting the full
				legal name, address, and date of birth of the recipient, the reporter shall
				include any middle name or initial and any suffix (e.g., Jr., II, III) as
				listed on the patient's government-issued photo identification card If the
				patient does not have such an identification card, such as a minor, then the
				reporter shall obtain and input the information to the best of his or her
				knowledge and ability based upon the information available to it from the
				prescription, the patient profile or record, and any other information known to
				the reporter. Examples of acceptable forms of ID include, but are not limited
				to: driver's licenses, non-driver identification cards, passports, and military
				IDs;
3.1.c. The Drug Enforcement
				Administration controlled substances registration number of the practitioner
				writing the prescription. By providing this registration number, the Controlled
				Substances Monitoring Program database will extract the prescriber's name and
				address required by statute; therefore, the reporters do not need to
				additionally supply the prescriber's name and address in addition to the
				prescriber's DEA number;
3.1.d. The
				national drug code number of the Schedule II, III, IV, or V controlled
				substance, drug of concern, or opioid antagonist dispensed. By providing this
				NDC number, the Controlled Substances Monitoring Program database will extract
				the name and dosage or strength of the controlled substance required by the
				statute such that the reporters do not need to additionally supply the name and
				dosage;
3.1.e. The quantity of the
				Schedule II, III, IV, or V controlled substance, drug of concern, or opioid
				antagonist dispensed;
3.1.f. The
				date the prescription was written and the date filled;
3.1.g. The number of refills, if any,
				authorized by the prescription;
3.1.h. If the prescription being dispensed is
				being picked up by a recipient representative on behalf of the recipient, the
				first and last name of the recipient representative as set forth on the
				person's government-issued photo identification card, the appropriate code for
				the type of ID, the ID number, the appropriate code indicating the relationship
				of the recipient representative to the patient, and the appropriate code for
				the issuing jurisdiction of the ID; and
3.1.i. The source of payment for the
				controlled substance, drug of concern, or opioid antagonist
				dispensed.